Milena C.
- Country
- Italy
- Department
- Immunoematologia e Trasfusioni
Research Overview
Data & Insights
Has run more than one trial at 0 of 21 partner sites.
Specializations
Hematology and Transfusion Medicine
Focus on disorders of blood formation, cellular therapies, and immune‑mediated hematologic complications.
- Acute Myeloid Leukemia
- Chronic Lymphocytic Leukemia
- Allogeneic Hematopoietic Stem Cell Transplantation
- Acute Graft‑Versus‑Host Disease
- B‑cell Lymphomas
Clinical investigations are conducted at Ospedale San Raffaele, integrating transfusion expertise with innovative cellular approaches.
Oncology – Advanced Solid Tumors
Targeted study of metastatic and refractory solid malignancies across multiple organ systems.
- Hormone Receptor‑Positive Breast Cancer
- Non‑Small Cell Lung Cancer
- Hepatocellular Carcinoma
- Clear Cell Renal Cell Carcinoma
- Urothelial Carcinoma
Efforts emphasize molecularly defined subgroups and novel therapeutic combinations for patients lacking standard options.
Autoimmune and Systemic Immune Disorders
Investigation of immune‑driven diseases with emphasis on pathogenesis and targeted immunomodulation.
- Systemic Lupus Erythematosus
- Diffuse Cutaneous Systemic Sclerosis
- Idiopathic Inflammatory Myopathies
- Vasculitis (e.g., EGPA)
- Autoimmune Thrombocytopenia
Research integrates serologic profiling with emerging biologic agents to modify disease trajectories.
Metabolic Liver Disease
Study of progressive fatty liver conditions and their cardiovascular and oncologic sequelae.
- Non‑Alcoholic Steatohepatitis (NASH)
- Non‑Alcoholic Fatty Liver Disease (NAFLD)
- Fibrosis Progression
- Hepatocellular Carcinoma Risk
- Metabolic Syndrome‑Associated Liver Injury
Projects address metabolic risk modulation and liver‑specific therapeutic endpoints.
Cardiovascular Metabolism and Atherosclerotic Disease
Exploration of lipid disorders, obesity, and cardiovascular risk in high‑risk patient cohorts.
- Atherosclerotic Cardiovascular Disease (ASCVD)
- Elevated Lipoprotein(a)
- Obesity‑Related Cardiometabolic Risk
- Heart Failure with Preserved Ejection Fraction
- Diabetes Mellitus Type 2
Investigations aim to link metabolic interventions with reduction of major adverse cardiovascular events.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.